Development of a patient reported outcome measure for fatigue in motor neurone disease: The Neurological Fatigue Index (NFI-MND)

Health and Quality of Life Outcomes

Volumn 9, Issue , 2011, Pages

  Gibbons, Chris J ^a,b   Mills, Roger J ^a   Thornton, Everard W ^b   Ealing, John ^c   Mitchell, John D ^d   Shaw, Pamela J ^e   Talbot, Kevin ^f   Tennant, A ^g   Young, Carolyn A ^a  

^a WALTON CENTRE FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c HOPE HOSPITAL   (United Kingdom)

^d ROYAL PRESTON HOSPITAL   (United Kingdom)

^e UNIVERSITY OF SHEFFIELD   (United Kingdom)

^f JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^g UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; ENERGY; FATIGUE; FEMALE; HEAT; HUMAN; INTERVIEW; MALE; MENTAL CONCENTRATION; MOTOR NEURON DISEASE; MUSCLE WEAKNESS; NEUROLOGIC EXAMINATION; NEUROLOGICAL FATIGUE INDEX; QUALITATIVE ANALYSIS; QUESTIONNAIRE; REST; TEST RETEST RELIABILITY; UNITED KINGDOM; VALIDITY; CLASSIFICATION; HOSPITALIZATION; METHODOLOGY; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PATHOPHYSIOLOGY; PSYCHOMETRY; QUALITATIVE RESEARCH; REPRODUCIBILITY; SICKNESS IMPACT PROFILE; STATISTICAL ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; DATA INTERPRETATION, STATISTICAL; FATIGUE; FEMALE; HUMANS; INTERVIEWS AS TOPIC; MOTOR NEURON DISEASE; OUTCOME ASSESSMENT (HEALTH CARE); PAIN MEASUREMENT; PSYCHOMETRICS; QUALITATIVE RESEARCH; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; SICKNESS IMPACT PROFILE; YOUNG ADULT;

EID: 81455160586     PISSN: None     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/1477-7525-9-101     Document Type: Article

References (23)

1. Lou JS, Reeves A, Benice T, Sexton G. Fatigue and depression are associated with poor quality of life in ALS. Neurology 2003, 60(1):122-123.
2. Ramirez C, Piemonte MEP, Callegaro D, Da Silva HCA. Fatigue in amyotrophic lateral sclerosis: Frequency and associated factors. Amyotroph Lateral Scler 2008, 9(2):75-80. 10.1080/17482960701642502, 17924237.
3. Chaudhuri A, Behan PO. Fatigue in neurological disorders. Lancet 2004, 363(9413):978-988. 10.1016/S0140-6736(04)15794-2, 15043967.
4. Adams R, Victor M, Ropper A. Principles of Neurology. 1997, Georgia: McGraw-Hill.
5. Rigby SA, Thornton EW, Tedman S, Burchardt F, Young CA, Dougan C. Quality of life assessment in MND: development of a Social Withdrawal Scale. J Neurol Sci 1999, 169(1-2):26-34. 10.1016/S0022-510X(99)00212-9, 10540004.
6. Smith J, Osborn M, . (eds.) Interpretive phenomenological analysis. 2003, London: Sage, (eds.).
7. Mills RJ, Young CA, Pallant JF, Tennant A. Development of a patient reported outcome scale for fatigue in multiple sclerosis: The Neurological Fatigue Index (NFI-MS). Health Qual Life Outcomes 2010, 8.
8. Gibbons CJ, Thornton EW, Young CA. The lived experience of fatigue in MND: a qualitative study from the patient's perspective. Amyotroph Lateral Scler 2010, 11(1):143-149.
9. Fisk JD, Ritvo PG, Ross L, Haase DA, Marrie TJ, Schlech WF. Measuring the functional impact of fatigue - initial validation of the Fatigue Impact Scale. Clin Infect Dis 1994, 18:S79-S83. 10.1093/clinids/18.Supplement_1.S79, 8148458.
10. Rasch G. Probabilistic models for some intelligence and attainment tests. 1960, Chicago: The University of Chicago Press.
11. Merbitz C, Morris J, Grip J. Ordinal scales and the foundations of misinference. Arch Phys Med Rehabil 1988, 70:303-313.
12. Pallant JF, Tennant A. An introduction to the Rasch measurement model: An example using the Hospital Anxiety and Depression Scale (HADS). Br J Clin Psychol 2007, 46:1-18. 10.1348/014466506X96931, 17472198.
13. Tennant A, Pallant J. Unidimensionality matters (a tale of two Smiths?). Rasch Meas Trans 2006, 20:1048-1051.
14. Browne M, Cudeck R. Alternative ways of assessing model fit. Testing Structural Equation Models 1993, 136-162. Newbury Park, CA: Sage, Bollen K, Long J.
15. Holland P, Wainer H. Differential Item Functioning. 1995, Philidelphia, PA: Laurence Erlbaum.
16. Choppin B. A fully conditional estimation procedure for Rasch model parameters. Centre for the Study of Evaluation 1983, Washington, D.C.: ERIC Clearinghouse, California Uo.
17. Andrich DLA, Sheridan B, Luo G. Rasch Unitary Measurement Model 2020 (RUMM2020). 2000, Perth, Australia: RUMM Laboratory Pty, 4.1 Build 194.
18. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986, 1(8476):307-310.
19. Krupp LB, Larocca NG, Muirnash J, Steinberg AD. The Fatigue Severity Scale - application to patients with multiple sclerosis and systemic lupus-erythematosus. Arch Neurol 1989, 46(10):1121-1123. 10.1001/archneur.1989.00520460115022, 2803071.
20. Smets EMA, Garssen B, Bonke B, Dehaes J. The Multidimensional Fatigue Inventory (MFI). Psychometeric qualities of an instrument to assess fatigue. J Psychosom Res 1995, 39(3):315-325. 10.1016/0022-3999(94)00125-O, 7636775.
21. Mills RJ, Young CA. A medical definition of fatigue in multiple sclerosis. Qjm-an International Journal of Medicine 2008, 101(1):49-60.
22. Mitchell JD, O'Brien MR. Quality of life in motor neurone disease - towards a more practical assessment tool?. J Neurol Neurosur Ps 2003, 74(3):287-288.
23. Doward LC, McKenna SP, Whalley D, Tennant A, Griffiths B, Emery P, Veale DJ. The development of the L-QoL: a quality-of-life instrument specific to systemic lupus erythematosus. Ann Rheum Dis 2009, 68(2):196-200. 10.1136/ard.2007.086009, 18385276.